Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Electroconvulsive therapy in patients with multiple sclerosis.

Keith G Rasmussen1, B Mark Keegan

  • 1Department of Psychiatry and Psycology, Mayo Clinic, Rochester, MN 55905, USA. rasmussen.keith@mayo.edu

The Journal of ECT
|September 7, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Pre-symptomatic phase of tumefactive multiple sclerosis mirrors radiologically isolated syndrome.

Multiple sclerosis and related disorders·2026
Same author

Spinal cord imaging for multiple sclerosis: Advances, priorities, and opportunities.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Generalizable spinal cord multiple sclerosis lesion segmentation across MRI contrasts, protocols, and centers.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Risk of Multiple Sclerosis Among Persons with Epstein Barr Virus-Positive Mononucleosis: A Population-Based Study.

Neurology open access·2026
Same author

Author response to letter.

Journal of the neurological sciences·2026
Same author

Brain MRI to detect cervical spinal cord critical demyelinating lesions in progressive MS.

Journal of the neurological sciences·2026
Same journal

Successful Use of Electroconvulsive Therapy in Treatment-Resistant Catatonia With Comorbid Parkinson Disease and Neuroborreliosis: A Case Report.

The journal of ECT·2026
Same journal

Electroconvulsive Therapy in Movement Disorders: A Systematic Review.

The journal of ECT·2026
Same journal

Presyncope During Repetitive Transcranial Magnetic Stimulation With Treatment Continuation.

The journal of ECT·2026
Same journal

Comparison of Electroconvulsive Therapy Seizure Outcomes When Using Methohexital Versus Propofol: A Brief Retrospective Report.

The journal of ECT·2026
Same journal

Changes in the Use of Repetitive Transcranial Magnetic Stimulation Therapy Between 2016 and 2022 in Northern Finland.

The journal of ECT·2026
Same journal

Evaluation of Cardiac Adverse Effects After Transition From Bitemporal to Bifrontal ECT.

The journal of ECT·2026
See all related articles

Electroconvulsive therapy (ECT) can be safely administered to patients with multiple sclerosis (MS) in the short term. Thorough neurological evaluation and informed consent are crucial before considering ECT for MS patients.

Area of Science:

  • Neurology
  • Psychiatry

Background:

  • Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system.
  • Electroconvulsive therapy (ECT) is a highly effective treatment for severe mood disorders.
  • Limited data exists on the safety and efficacy of ECT in patients with MS.

Observation:

  • Three patients with multiple sclerosis underwent electroconvulsive therapy.
  • All patients received safe and effective ECT.
  • No acute neurological deterioration was observed during or after ECT.

Findings:

  • Electroconvulsive therapy (ECT) can be a safe and effective short-term treatment option for patients with multiple sclerosis (MS).
  • Pre-ECT neurological evaluation and comprehensive informed consent discussions are essential.

Related Experiment Videos

  • Potential risks, including neurological deterioration, must be discussed with patients.

    • Implications:

    • ECT may be considered for select MS patients experiencing severe mood disorders.
    • Further research is needed to ascertain long-term outcomes and safety profiles of ECT in MS.
    • This study contributes to the limited but growing evidence base for managing comorbid psychiatric and neurological conditions.